Journal of Medicinal Chemistry · 2011 · 31 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignNeuropharmacologyStructure-activity RelationshipsEnzyme InhibitionQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisBiological Evaluation ReportMedicinal Chemistry ApplicationsNeuroactive CompoundsNitric OxideStructure - Activity Relationship OptimizationThermal Hyperalgesia
Neuronal nitric oxide synthase (nNOS) inhibitors are effective in preclinical models of many neurological disorders. In this study, two related series of compounds, 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline, containing a 6-substituted thiophene amidine group were synthesized and evaluated as inhibitors of human nitric oxide synthase (NOS). A structure-activity relationship (SAR) study led to the identification of a number of potent and selective nNOS inhibitors. Furthermore, a few representative compounds were shown to possess druglike properties, features that are often difficult to achieve when designing nNOS inhibitors. Compound (S)-35, with excellent potency and selectivity for nNOS, was shown to fully reverse thermal hyperalgesia when given to rats at a dose of 30 mg/kg intraperitonieally (ip) in the L5/L6 spinal nerve ligation model of neuropathic pain (Chung model). In addition, this compound reduced tactile hyperesthesia (allodynia) after oral administration (30 mg/kg) in a rat model of dural inflammation relevant to migraine pain.
21
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Paul L. Huang, Zhihong Huang, Hiroshi Mashimo et al. · Nature · 1995 · 2.1K citations
Life Sciences, Genetics, Physiology +12